Clinical Trial Update: A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control Epilepsy [Phase 2]

View source ↗

Summary

The Phase 2 study of Topiramate in patients with difficult-to-control epilepsy has completed, reporting on its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Epilepsy, Epilepsies, Partial | Phase 2 | Status: COMPLETED